Literature DB >> 18176851

Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutation.

Kory W Jasperson1, Kathleen R Blazer, Katrina Lowstuter, Jeffrey N Weitzel.   

Abstract

The two most common causes of hereditary colorectal cancer are Lynch syndrome and familial adenomatous polyposis (FAP). The phenotype of Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer (HNPCC), is differentiated in part from FAP by the lack of profuse colonic polyposis. Here we describe a proband who presented with greater than 50 adenomatous colonic polyps prior to developing cancer of the colon and urinary bladder, and a family history that fulfills the Amsterdam criteria. Germline analyses of APC and MYH in the proband did not reveal any mutations. Comprehensive analysis of the mismatch repair genes associated with Lynch syndrome revealed a germline hMSH6 missense mutation 2314C>T (arg772trp) and normal sequencing for hMSH2 and hMLH1. We outline evidence supporting the pathogenicity of the identified hMSH6 mutation (arg772trp) and suggest possible etiologies for the unexplained colonic adenomatous polyposis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18176851     DOI: 10.1007/s10689-007-9179-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  22 in total

1.  Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas.

Authors:  N E Beck; I P Tomlinson; T F Homfray; I M Frayling; S V Hodgson; W F Bodmer
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

2.  Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype.

Authors:  N Ohmiya; S Matsumoto; H Yamamoto; S Baranovskaya; S R Malkhosyan; M Perucho
Journal:  Gene       Date:  2001-07-11       Impact factor: 3.688

Review 3.  The ABC of APC.

Authors:  N S Fearnhead; M P Britton; W F Bodmer
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

4.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Double frameshift mutations in APC and MSH2 in the same individual.

Authors:  Claudio Soravia; Celia D DeLozier; Zuzana Dobbie; Claudine Rey Berthod; Eviano Arrigoni; Marie-Anne Bründler; Jean-Louis Blouin; William D Foulkes; Pierre Hutter
Journal:  Int J Colorectal Dis       Date:  2006-01       Impact factor: 2.571

6.  Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue.

Authors:  Jens Plaschke; Stefan Krüger; Wolfgang Dietmaier; Johannes Gebert; Christian Sutter; Elisabeth Mangold; Constanze Pagenstecher; Elke Holinski-Feder; Karsten Schulmann; Gabriela Möslein; Josef Rüschoff; Christoph Engel; Gareth Evans; Hans K Schackert
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

7.  I1307K APC and hMLH1 mutations in a non-Jewish family with hereditary non-polyposis colorectal cancer.

Authors:  Z Q Yuan; L Kasprzak; P H Gordon; L Pinsky; W D Foulkes
Journal:  Clin Genet       Date:  1998-10       Impact factor: 4.438

Review 8.  Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature.

Authors:  Yangming Cao; Maura Pieretti; Jay Marshall; Nada H Khattar; Bifen Chen; Lauren Kam-Morgan; Henry Lynch
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

9.  MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.

Authors:  Stefan Aretz; Siegfried Uhlhaas; Heike Goergens; Kirsten Siberg; Matthias Vogel; Constanze Pagenstecher; Elisabeth Mangold; Reiner Caspari; Peter Propping; Waltraut Friedl
Journal:  Int J Cancer       Date:  2006-08-15       Impact factor: 7.396

10.  The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.

Authors:  Andrea E De Jong; Hans Morreau; Marjo Van Puijenbroek; Paul H c Eilers; Juul Wijnen; Fokko M Nagengast; Gerrit Griffioen; Annemieke Cats; Fred H Menko; Jan H Kleibeuker; Hans F A Vasen
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

View more
  4 in total

Review 1.  Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer.

Authors:  Daniel D Buchanan; Aedan Roberts; Michael D Walsh; Susan Parry; Joanne P Young
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

2.  ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Authors:  Colin C Pritchard; Christina Smith; Stephen J Salipante; Ming K Lee; Anne M Thornton; Alex S Nord; Cassandra Gulden; Sonia S Kupfer; Elizabeth M Swisher; Robin L Bennett; Akiva P Novetsky; Gail P Jarvik; Olufunmilayo I Olopade; Paul J Goodfellow; Mary-Claire King; Jonathan F Tait; Tom Walsh
Journal:  J Mol Diagn       Date:  2012-05-30       Impact factor: 5.568

3.  Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.

Authors:  Michael D Walsh; Daniel D Buchanan; Rhiannon Walters; Aedan Roberts; Sven Arnold; Diane McKeone; Mark Clendenning; Andrew R Ruszkiewicz; Mark A Jenkins; John L Hopper; Jack Goldblatt; Jillian George; Graeme K Suthers; Kerry Phillips; Graeme P Young; Finlay Macrae; Musa Drini; Michael O Woods; Susan Parry; Jeremy R Jass; Joanne P Young
Journal:  Fam Cancer       Date:  2009-02-25       Impact factor: 2.375

4.  Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study.

Authors:  Nasir Kamat; Mohammed A Khidhir; Mouied M Alashari; Ulf Rannug
Journal:  Oncol Lett       Date:  2013-09-12       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.